Five Below Stock Surges 114% in Trading Volume, Ranks 395th in Daily Market

On May 27, 2025, Five Below (FIVE) saw a significant surge in trading volume, with a turnover of $25.4 million, marking an 114.32% increase from the previous day. This substantial rise in trading activity placed Five Below at the 395th position in the daily stock market rankings. The stock price of Five Below also experienced a notable increase, rising by 8.23%.

Five individuals, including a former director of Chinook Therapeutics' board, have been charged with participating in an insider trading scheme related to Novartis' acquisition of Chinook Therapeutics. Rouzbeh Haghighat, who served on Chinook's board until the 2023 acquisition, is accused of securities fraud, insider trading, and conspiracy. He allegedly viewed material nonpublic information about the Novartis-Chinook buyout and tipped off others, leading to profits exceeding $600,000 before the acquisition was publicly announced.

Haghighat's resignation from Sernova Biotherapeutics, where he served as chairman, followed the public announcement of the charges. The biotech company acknowledged his service and wished him well in his future endeavors. The case highlights the severe penalties associated with securities fraud and insider trading, with potential prison sentences ranging from 20 to 25 years per count.